SUN-684 Anti-Obesity Effects of HSYA through Inducing Lac-Phe and Inhibiting GIP

Abstract Disclosure: W. Hu: None. K. Yan: None. X. Lyu: None. X. Guo: None. Z. Zhou: None. Y. Zhao: None. L. Wang: None. H. Yang: None. H. Zhu: None. H. Pan: None. Q. Yang: None. F. Gong: None. Hydroxysafflor yellow A (HSYA), the primary bioactive compound in safflower (Carthamus tinctorius), has been shown in our previous studies to reduce feeding efficiency and prevent diet-induced obesity (DIO) by inhibiting glucose-dependent insulinotropic polypeptide (GIP) production. To investigate the underlying mechanisms of HSYA-inhibited GIP production, we performed metabolomics analysis of cecal contents from HSYA and vehicle-treated DIO mice. N-lactoyl-phenylalanine (Lac-Phe) emerged as one of the most significantly upregulated metabolites in HSYA-treated mice compared to controls. To determine the source of Lac-Phe production, we co-administered HSYA with antibiotics in DIO mice to deplete the gut microbiome. Antibiotics treatment did not reduce the elevated Lac-Phe levels in HSYA-treated mice, indicating that the gut microbiome is not the primary source of Lac-Phe production. We then investigated whether Lac-Phe could be generated by the small intestine. RT-PCR and immunohistochemistry analysis of the small intestine revealed that carnosine dipeptidase II (CNDP2), the sole synthetase of Lac-Phe, was upregulated by HSYA. Furthermore, treating Caco-2 cells with HSYA increased CNDP2 expression and Lac-Phe production, while CNDP2 knockdown abolished the HSYA-induced Lac-Phe elevation. These results suggest that HSYA increases Lac-Phe synthesis in the intestinal epithelial cells. To explore whether Lac-Phe is involved in GIP suppression by HSYA, we treated enteroendocrine STC-1 cells with Lac-Phe and found that GIP expression and production were significantly reduced. These findings suggest that HSYA exerts its anti-obesity effects by inducing Lac-Phe production in intestinal epithelial cells, which in turn reduces GIP secretion in intestinal enteroendocrine cells, dually leading to suppressed food efficiency and weight loss in DIO mice. Presentation: Sunday, July 13, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.193
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SUN-684 Anti-Obesity Effects of HSYA through Inducing Lac-Phe and Inhibiting GIP

Xiaorui Lyu, Hongbo Yang, Fengying Gong, Qin Yang et al.
Journal of the Endocrine Society
Pharmacology and Obesity Treatment
article

SUN-684 Anti-Obesity Effects of HSYA through Inducing Lac-Phe and Inhibiting GIP

Xiaorui Lyu, Hongbo Yang, Fengying Gong, Qin Yang, Wenjing Hu, Xiaonan Guo, Huijuan Zhu, Linjie Wang, Zhibo Zhou, Hui Pan, Yuxing Zhao, Kemin Yan
article en

Abstract

Abstract Disclosure: W. Hu: None. K. Yan: None. X. Lyu: None. X. Guo: None. Z. Zhou: None. Y. Zhao: None. L. Wang: None. H. Yang: None. H. Zhu: None. H. Pan: None. Q. Yang: None. F. Gong: None. Hydroxysafflor yellow A (HSYA), the primary bioactive compound in safflower (Carthamus tinctorius), has been shown in our previous studies to reduce feeding efficiency and prevent diet-induced obesity (DIO) by inhibiting glucose-dependent insulinotropic polypeptide (GIP) production. To investigate the underlying mechanisms of HSYA-inhibited GIP production, we performed metabolomics analysis of cecal contents from HSYA and vehicle-treated DIO mice. N-lactoyl-phenylalanine (Lac-Phe) emerged as one of the most significantly upregulated metabolites in HSYA-treated mice compared to controls. To determine the source of Lac-Phe production, we co-administered HSYA with antibiotics in DIO mice to deplete the gut microbiome. Antibiotics treatment did not reduce the elevated Lac-Phe levels in HSYA-treated mice, indicating that the gut microbiome is not the primary source of Lac-Phe production. We then investigated whether Lac-Phe could be generated by the small intestine. RT-PCR and immunohistochemistry analysis of the small intestine revealed that carnosine dipeptidase II (CNDP2), the sole synthetase of Lac-Phe, was upregulated by HSYA. Furthermore, treating Caco-2 cells with HSYA increased CNDP2 expression and Lac-Phe production, while CNDP2 knockdown abolished the HSYA-induced Lac-Phe elevation. These results suggest that HSYA increases Lac-Phe synthesis in the intestinal epithelial cells. To explore whether Lac-Phe is involved in GIP suppression by HSYA, we treated enteroendocrine STC-1 cells with Lac-Phe and found that GIP expression and production were significantly reduced. These findings suggest that HSYA exerts its anti-obesity effects by inducing Lac-Phe production in intestinal epithelial cells, which in turn reduces GIP secretion in intestinal enteroendocrine cells, dually leading to suppressed food efficiency and weight loss in DIO mice. Presentation: Sunday, July 13, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
University of California, Irvine (US), Peking Union Medical College Hospital (CN), Irvine University (US)
Openalex Percentile: Top 66%
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.